Connect with us
SunRock Biopharma, a Galician biotech firm, develops next-generation antibody-based drugs targeting resistant cancers and immune diseases. Founded by Laureano Simón, it focuses on early clinical phases...
Castile and León’s Health Ministry launched its 2025–2030 Strategy for Advanced Therapies to boost innovation in biotech and regenerative medicine. Key goals include doubling clinical trials,...
A CNIC-led study published in Nature identifies imidazole propionate (ImP), a gut-derived metabolite, as a blood biomarker and causal agent of early atherosclerosis. ImP activates systemic...
Sarcomas are rare malignant tumors of connective tissue, representing a small cancer percentage but posing major treatment challenges. Advanced biotechnology, especially CAR-T immunotherapies, offers hope. CIBERONC...
Spain’s Ministry of Science has awarded €126.9M in subsidies to companies in the EU-backed IPCEI Med4Cure project. The initiative supports healthcare innovation, advanced therapies, and sustainable...
The €196.4 million Biotech Booster fund in the Netherlands supports scientists and research teams to turn biotech innovations into market-ready solutions. Funded by the National Growth...
Ecnoglutide, a once-weekly GLP-1 receptor agonist, showed up to 13.2% weight loss over 40 weeks in obese or overweight adults without diabetes in a Phase III...
Vytrus Biotech’s 2024 Sustainability Report highlights major progress in plant stem cell innovation, resource savings, and ESG efforts. Key achievements include award-winning product Baolift™, strong certifications,...
Pfizer Spain’s 2024 Impact Report highlights its leadership in clinical research, €54M R&D investment, four new treatments, and 113 trials across 13 areas. Marking Pfizer’s 175th...
Obesity, diabetes, and cardiovascular disease are increasingly common in the population. Brown adipose tissue plays a protective role against these prevalent diseases, as it burns calories...